Skip to main content
Log in

Exploring the myths of morphine in cancer: views of the general practice population

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Background

Morphine is widely used in cancer care, and understanding the concerns and perceptions of patients, family and friends is vital to managing pain and distress effectively. The ‘myths of morphine’ have frequently been discussed in medical literature, yet the extent to which such views are held is not clear. This qualitative project explores the perceptions and attitudes of the wider community towards morphine use in cancer care, to understand this ‘mythology’ according to those who in the future may themselves require its use.

Methods

Semi-structured interviews were held with patients presenting to a metropolitan general practice clinic in Melbourne, Australia. A grounded theory framework underpinned the data collection and thematic analysis undertaken.

Results

Interviewees (15) were aged 24–81, with a variety of experiences with cancer care and previous morphine use. Interviewees were highly supportive of morphine use in cancer care, with this attitude founded on the perceived severity of cancer pain and the powerful nature of morphine. They described a number of reasons morphine may be used in cancer care: to treat pain, to enable peace and also as a treatment for cancer.

Conclusion

The public view of morphine to emerge from this study is markedly different from that discussed in the myths of morphine. It is viewed as a medication that has the ability to provide peace and control both pain and the course of cancer. The participants in this study described a wish for greater involvement in pain control decisions, perceiving morphine as a facilitator rather than a barrier to good cancer care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Clark D (1999) ‘Total pain’, disciplinary power and the body in the work of Cicely Saunders, 1958-1967. Soc Sci Med 49(6):727–736

    Article  CAS  PubMed  Google Scholar 

  2. Potter VT, Wiseman CE, Dunn SM, Boyle FM (2003) Patient barriers to optimal cancer pain control. Psychooncology 12(2):153–160

    Article  PubMed  Google Scholar 

  3. Manderson DRA (1988) The first loss of freedom: early opium laws in Australia. Aust Drug Alcohol Rev 7(4):439–453

    Article  Google Scholar 

  4. Grant M, Philip J, Ugalde A (2014) A functional dependence? A social history of the medical use of morphine in Australia. Med J Aust 200(4):230–232

    Article  PubMed  Google Scholar 

  5. Flemming K (2010) The use of morphine to treat cancer-related pain: a synthesis of quantitative and qualitative research. J Pain Symptom Manag 39(1):139–154

    Article  CAS  Google Scholar 

  6. Reid CM, Gooberman-Hill R, Hanks GW (2008) Opioid analgesics for cancer pain: symptom control for the living or comfort for the dying? A qualitative study to investigate the factors influencing the decision to accept morphine for pain caused by cancer. Ann Oncol 19(1):44–48

    Article  CAS  PubMed  Google Scholar 

  7. Maltoni M (2008) Opioids, pain, and fear. Ann Oncol 19(1):5–7

    Article  CAS  PubMed  Google Scholar 

  8. Shoemaker PJ (1989) Communication campaigns about drugs: government, media, and the public: L. Erlbaum Associates, Hillsdale, NJ

  9. Oxberry SG, Jones L, Clark AL, Johnson MJ (2012) Attitudes to morphine in chronic heart failure patients. Postgrad Med J 88(1043):515–521

    Article  PubMed  Google Scholar 

  10. Zenz M (1991) Morphine myths: sedation, tolerance, addiction. Postgrad Med J 67:S100

    PubMed  Google Scholar 

  11. Forbes K (2006) Opioids: beliefs and myths. J Pain Palliat Care Pharmacother 20(3):33–35

    PubMed  Google Scholar 

  12. Doyle D (1991) Morphine: myths, morality and economics. Postgrad Med J 67(Suppl 2):S70–S73

    PubMed  Google Scholar 

  13. Elliott TE, Elliott BA (1992) Physician attitudes and beliefs about use of morphine for cancer pain. J Pain Symptom Manag 7(3):141–148

    Article  CAS  Google Scholar 

  14. Lossignol DA (1993) Pitfalls in the use of opiates in treatment of cancer pain. Support Care Cancer 1(5):256–258

    Article  CAS  PubMed  Google Scholar 

  15. Ersek M, Miller Kraybill B, Du Pen A (1999) Factors hindering patients’ use of medications for cancer pain. Cancer Pract 7(5):226–232

    Article  CAS  PubMed  Google Scholar 

  16. Bennett MI, Graham J, Schmidt-Hansen M, Prettyjohns M, Arnold S (2012) Prescribing strong opioids for pain in adult palliative care: summary of NICE guidance. BMJ Br Med J 344:42

    Article  Google Scholar 

  17. Ward SE, Goldberg N, Miller-McCauley V, Mueller C, Nolan A, Pawlik-Plank D et al (1993) Patient-related barriers to management of cancer pain. Pain 52(3):319–324

    Article  CAS  PubMed  Google Scholar 

  18. Gunnarsdottir S, Donovan HS, Serlin RC, Voge C, Ward S (2002) Patient-related barriers to pain management: the barriers questionnaire II (BQ-II). Pain 99(3):385–396

    Article  PubMed  Google Scholar 

  19. Paice JA, Toy C, Shott S (1998) Barriers to cancer pain relief: fear of tolerance and addiction. J Pain Symptom Manag 16(1):1–9

    Article  CAS  Google Scholar 

  20. Seymour JE, Bellamy G, Gott M, Ahmedzai SH, Clark D (2002) Good deaths, bad deaths: older people’s assessments of the risks and benefits of morphine and terminal sedation in end-of-life care. Health Risk Soc 4(3):287–303

    Article  Google Scholar 

  21. Halldórsdóttir S, Hamrin E (1996) Experiencing existential changes: the lived experience of having cancer. Cancer Nurs 19(1):29–36

    Article  PubMed  Google Scholar 

  22. Zenz M, Sorge J (1991) Is the therapeutic use of opioids adversely affected by prejudice and law? In: Senn H-J, Glaus A (eds). Supportive care in cancer patients II. Recent results in cancer research. 121. Springer, Heidelberg, pp 43–50

  23. Momen N, Hadfield P, Harrison K, Barclay S (2012) Managing pain in advanced cancer: a survey of United Kingdom general practitioners and community nurses. J Pain Symptom Manage 46(3):345–54

  24. Britt H, Miller GC, Charles J, Henderson J, Bayram C, Pan Y, et al (2009) General practice activity in Australia 2008-09: Australian Institute of Health and Welfare, and University of Sydney

  25. Vafiadis P (2001) Mutual care in palliative medicine: a story of doctors and patients. Roseville, N.S.W. McGraw-Hill, Australia

Download references

Conflict of interest

Matthew Grant was previously employed as a pharmacovigilance physician by MSD; however, he has no ongoing relationship with the company.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Matthew Grant.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Grant, M., Ugalde, A., Vafiadis, P. et al. Exploring the myths of morphine in cancer: views of the general practice population. Support Care Cancer 23, 483–489 (2015). https://doi.org/10.1007/s00520-014-2379-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-014-2379-9

Keywords

Navigation